Results

eNauka >  Results >  Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Title: Vedolizumab Clearance as a Surrogate Marker for Remission in Inflammatory Bowel Disease Patients: Insights from Real-World Pharmacokinetics
Authors: Marković, Srđan  ; Kralj, Ðorđe; Svorcan, Petar  ; Knežević-Ivanovski, Tamara; Odanović, Olga; Obradović, Sanja; Homšek, Ana  ; Jovanović, Marija  ; Savić, Rada; Vučićević, Katarina  
Issue Date: 2024
Publication: Pharmaceutics
ISSN: 1999-4923 Pharmaceutics Search Idenfier
Publisher: Basel, Switzerland : MDPI
Type: Article
Collation: vol. 16 br. 12 str. 1629
DOI: 10.3390/pharmaceutics16121629
WoS-ID: 001383959700001
Scopus-ID: 2-s2.0-85213373736
PMID: 39771608
PMCID: PMC11677246
URI: https://farfar.pharmacy.bg.ac.rs/handle/123456789/5892
https://enauka.gov.rs/handle/123456789/958470
URL: https://www.mdpi.com/1999-4923/16/12/1629
Project: optYmAb - Improving Clinical Outcomes with Precision Dosing in Patients with Inflammatory Bowel Disease Through Investigating Variability of Monoclonal Antibodies Based on Population Pharmacokinetic-Pharmacodynamic Modeling
M-category: 
21aM21a

4
SCOPUSTM
2
PubMed CentralTM
3
WEB OF SCIENCETM
Altmetric
Dimensions
Unpaywall

Creative Commons License